Multicenter randomized study on Me-CCNU, 5-FU and ADMvsACNU, 5-FU and ADM for treatment of advanced gastric cancer | Zendy

Shudong Xiao | Zendy; Dehua Li | Zendy; Zhang De-zhong | Zendy; Mou-Ji Shen | Zendy; Xiaoting Zhu | Zendy; Guifen He | Zendy; Tiping Zhao | Zendy; Leping Li | Zendy; Xing-Cun Deng | Zendy; Min Wang | Zendy; Xiuling Wang | Zendy; Qiang Chen | Zendy; Yongping Zhang | Zendy; Cui-Ling Yao | Zendy; Ji-Gui Bao | Zendy; Tong Guo-wei | Zendy; Liang-Fa Zhu | Zendy; Hao Jiang | Zendy; Minoru Kurihara | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Multicenter randomized study on Me-CCNU, 5-FU and ADMvsACNU, 5-FU and ADM for treatment of advanced gastric cancer

Author(s) -

Shudong Xiao,

Dehua Li,

Zhang De-zhong,

Mou-Ji Shen,

Xiaoting Zhu,

Guifen He,

Tiping Zhao,

Leping Li,

Xing-Cun Deng,

Min Wang,

Xiuling Wang,

Qiang Chen,

Yongping Zhang,

Cui-Ling Yao,

Ji-Gui Bao,

Tong Guo-wei,

Liang-Fa Zhu,

Hao Jiang,

Minoru Kurihara

Publication year - 1997

Publication title -

world journal of gastroenterology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.427

H-Index - 155

eISSN - 2219-2840

pISSN - 1007-9327

DOI - 10.3748/wjg.v3.i4.238

Subject(s) - medicine , quality of life (healthcare) , regimen , nitrosourea , randomized controlled trial , group b , gastroenterology , adverse effect , cancer , chemotherapy , oncology , nursing

To compare the efficacy of a combined chemotherapy regimen of 5-fluouracil (5-FU) and adriamycin (ADM) with nimustine hydrochloride (ACNU; brand name Nidran), a new nitrosourea agent, or with methyl-CCNU for advanced gastric cancer.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research